Application of PET/CT to adjuvant chemotherapy for early lung adenocarcinoma

S Sasada, Y Miyata, T Mimae, Y Tsutani… - Journal of …, 2015 - go.gale.com
Method We reviewed 174 consecutive patients with completely resected pathological T1b-
2aN0M0 lung adenocarcinoma between January 2006 and March 2011, and assessed …

Role of positron emission tomography/computed tomography findings for adjuvant chemotherapy indications in stage T1b-2aN0M0 lung adenocarcinoma

S Sasada, Y Miyata, N Tsubokawa, T Mimae… - The Annals of Thoracic …, 2014 - Elsevier
Background This study aimed to determine the significance of the maximum standardized
uptake value (SUV max) on 18F-fluorodeoxyglucose positron emission …

Prognostic value of preoperative FDG-PET in stage IA lung adenocarcinoma

S Murakami, H Saito, Y Sakuma, T Kondo… - European journal of …, 2012 - Elsevier
BACKGROUND: Maximum standardized uptake value (SUVmax) of 18F-fluorodeoxyglucose
positron emission tomography (FDG-PET) has been found to have prognostic value. We …

Prognostic impact of FDG-PET in surgically treated pathological stage I lung adenocarcinoma

M Higuchi, T Hasegawa, J Osugi, H Suzuki… - Annals of Thoracic and …, 2014 - jstage.jst.go.jp
Purpose: This retrospective study evaluated whether the maximum standardized uptake
value (SUVmax) on 18F-deoxyglucose (FDG)-positron emission tomography (PET) could be …

Role of PET scan in predicting response to neoadjuvant chemotherapy and long-term outcomes for stage II lung cancer.

A Bharat, B Guenthart, VW Rusch, MS Bains, NP Rizk - 2014 - ascopubs.org
7574 Background: While the role of neo-adjuvant chemotherapy (NAT) in stage IIIA non-
small cell lung cancer (NSCLC) is well established, its efficacy in stage II is unclear. We …

[HTML][HTML] Prognostic value of preoperative positron emission tomography in resected stage I non-small cell lung cancer

B Goodgame, GA Pillot, Z Yang, J Shriki… - Journal of Thoracic …, 2008 - Elsevier
Purpose Approximately 20 to 40% of patients with surgically resected stage I non-small cell
lung cancer (NSCLC) will develop recurrent disease. Positron emission tomography (PET) …

Prognostic role of positron emission tomography and high-resolution computed tomography in clinical stage IA lung adenocarcinoma

H Uehara, Y Tsutani, S Okumura, H Nakayama… - The Annals of Thoracic …, 2013 - Elsevier
Background This multicenter study aimed to validate the ability of 18 F-fluorodeoxyglucose
positron emission tomography/computed tomography (PET/CT) plus high-resolution …

Does FDG PET/CT have a role in determining adjuvant chemotherapy in surgical margin-negative stage IA non-small cell lung cancer patients?

HL Park, IR Yoo, SH Boo, SY Park, JK Park… - Journal of Cancer …, 2019 - Springer
Purpose To evaluate the prognostic value of FDG PET/CT metabolic parameter compared to
clinico–pathological risk factors in surgical margin-negative stage IA non-small cell lung …

[HTML][HTML] Positron emission tomography/computed tomography and lymphovascular invasion predict recurrence in stage I lung cancers

S Shiono, M Abiko, T Sato - Journal of Thoracic Oncology, 2011 - Elsevier
Background: Although pathologic stage I lung cancers generally have a favorable
prognosis, approximately 20% of patients experience recurrence after surgery. Therefore, a …

FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma

K Kadota, C Colovos, K Suzuki, NP Rizk… - Annals of surgical …, 2012 - Springer
Background We investigated the association between the newly proposed International
Association for the Study of Lung Cancer (IASLC)/American Thoracic Society …